Your Messege:
Your Name:(Required)
 
Email Address:(Required)
 
Message:
 
 

To view the weather click here.
Bringing cheap and accurate tuberculosis tests to Africa Bringing cheap and accurate tuberculosis tests to Africa
For a previous project also funded by the Gates Foundation, Salus Discovery researchers provide training to Uganda-based staff on a new diagnostic test for HIV/AIDS. Field training for the new tuberculosis test will begin in spring 2018 in Ethiopia and South Africa. Credit: Salus Discovery ...
2018/1/18
New Diagnostics Tool, the Xpert Ultra Assay, Improves Detection of Mycobacterium tuberculosis New Diagnostics Tool, the Xpert Ultra Assay, Improves Detection of Mycobacterium tuberculosis
Researchers have demonstrated a new, improved version of the Xpert MTB/RIF assay, a test for Rifampicin-resistance (RIF-R). The Xpert “Ultra” assay overcomes the shortcomings of the current Xpert assay to significantly improve tuberculosis detection, especially in patients with pauci-bacillary disease. The new Xpert Ultra ...
2018/1/18
New antifungal provides hope in fight against superbugs New antifungal provides hope in fight against superbugs
Microscopic yeast have been wreaking havoc in hospitals around the world—creeping into catheters, ventilator tubes, and IV lines—and causing deadly invasive infection. One culprit species, Candida auris, is resistant to many antifungals, meaning once a person is infected, there are limited treatment options. But in ...
2018/1/16
Re-programming innate immune cells to fight tuberculosis Re-programming innate immune cells to fight tuberculosis
Tuberculosis (TB), an infectious disease which attacks the lungs, claims someone's life every 20 seconds and 1.5 million lives worldwide every year. A cure has eluded scientists for more than a century but, now, researchers may have discovered a new weapon to combat this global ...
2018/1/16
Turning pathogens against each other to prevent drug resistance Turning pathogens against each other to prevent drug resistance
Limiting a much-needed resource could pit pathogens against one another and prevent the emergence of drug resistance. New research demonstrates that harnessing competition among pathogens inside a patient could extend the life of existing drugs where resistance is already present and prevent resistance to new ...
2018/1/11
Researchers discover cluster of multidrug-resistant tuberculosis pathogens Researchers discover cluster of multidrug-resistant tuberculosis pathogens
Between February and November 2016, the Institute of Medical Microbiology at the University of Zurich discovered a multidrug-resistant Mycobacterium tuberculosis in eight refugees arriving in Europe from the Horn of Africa. The analyses provided an impulse for launching a transnational investigation and developing a pan-European ...
2018/1/11
A fast, cheap urine test for tuberculosis may soon be possible A fast, cheap urine test for tuberculosis may soon be possible
Tuberculosis is the top infectious cause of death globally, but diagnosis is long and difficult. Now, a simple test can be carried out by untrained medical workers in minutes
2018/1/8
Tuberculosis drugs work better with vitamin C Tuberculosis drugs work better with vitamin C
Studies in mice and in tissue cultures suggest that giving vitamin C with tuberculosis drugs could reduce the unusually long time it takes these drugs to eradicate this pathogen.
2018/1/8
95,000 tuberculosis cases reported in Bihar last year 95,000 tuberculosis cases reported in Bihar last year
Additional executive director of State Health Society Sanjay Kumar Singh on Thursday expressed concern over lack of tuberculosis test facility at integrated counselling and test centres (ICTCs) and antiretroviral therapy (ART) centres where HIV patients co-infected with multi-drug resistant (MDR) TB visit.
2018/1/2
Scientists take major step forward in research efforts to develop TB vaccine Scientists take major step forward in research efforts to develop TB vaccine
A team of scientists led by the University of Southampton has taken an important step forward in research efforts that could one day lead to an effective vaccine against the world's deadliest infectious disease.
2018/1/2
Mycobacteria use protein to create diverse populations, avoid drugs Mycobacteria use protein to create diverse populations, avoid drugs
Subgroups of tuberculosis-causing bacteria can persist even when antibiotics wipe out most of the population. The need to eliminate these persistent subpopulations is one reason why TB treatment regimens are so lengthy. Now, NIAID-supported researchers have shown that a single protein allows mycobacteria to generate ...
2017/12/31
Blocking TB germs' metabolic 'escape pathways' may be key to better, shorter treatment Blocking TB germs' metabolic 'escape pathways' may be key to better, shorter treatment
New research suggests the bacteria that cause tuberculosis alter their metabolism to combat exposure to antimicrobials, and that these metabolic 'escape pathways' might be neutralized by new drugs to shorten the troublesome duration of therapy.
2017/12/31
New TB drugs possible with understanding of old antibiotic New TB drugs possible with understanding of old antibiotic
Tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs, thanks to new research into an old antibiotic by the University of Warwick and The Francis Crick Institute.
2017/12/27
Progression from infection to pulmonary tuberculosis follows distinct timeline Progression from infection to pulmonary tuberculosis follows distinct timeline
Researchers have uncovered a sequence of biological processes that occur in humans infected with the bacterium Mycobacterium tuberculosis as the infection progresses to pulmonary tuberculosis, according to new research published in PLOS Pathogens.
2017/12/27
New small-molecule drug restores brain function, memory in mouse model of Alzheimer's disease New small-molecule drug restores brain function, memory in mouse model of Alzheimer's disease
An international team of researchers has shown that a new small-molecule drug can restore brain function and memory in a mouse model of Alzheimer's disease.
2017/12/27
Join The AASM
AASM log in page
Membership fee
Contact us
Links
2018 Jan 21
Last changed   2018/1/18
Webmaster noreply@theaasm.org

Did you know that Aboalis Avicenne (980-1037)

was the first doctor who described three stages

for tuberculosis.  In his book

Canin  de La Medicine he named them as :

*.Stade de preinflammatoire

*.Stade de ulcere rongeant

*.Stade de Caverne


Copyright © 2011 AASM. All Rights Reserved.